Waterstone is an international pharmaceutical company with its main operations in
China. The company is focused in discovery, development and commercialization of
innovative drugs for the treatment of liver and gastrointestinal diseases. With
venture capital investments from internationally well-known firms such as BAR
Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully
integrated capabilities from R&D, API & Finished Drug Product manufacturing to
sales/marketing. The company has a strong management team with cross-border
experience and advisors with expertise in drug discovery, regulatory, and GMP
manufacturing. the company has also built a rich pipeline including Drug Master
Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several
novel preclinical stage antiviral and oncology candidates.
Waterstone is an international bio-pharmaceutical company committed to the discovery, development and commercilization of therapeutics for significant unmet medical needs
Mobile Scan,Learn more